BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 7140941)

  • 1. [The effects of ticlopidine on platelet aggregation: study on 13 atherosclerotic patients].
    Lenci R; Galante A; Borzi M; Ariganello M; Sommariva L; Filice A; Cannata D
    Clin Ter; 1983 Feb; 104(3):205-9. PubMed ID: 6861457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ticlopidine as something more than a platelet antiaggregant].
    Villaverde C; Cánovas M; Padró T; Navarro C
    Arch Farmacol Toxicol; 1984 Aug; 10(2):121-32. PubMed ID: 6517621
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of platelet aggregation in patients treated with ticlopidine].
    Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
    Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of ticlopidine on platelet function and blood coagulation.
    Violi F; Alessandri C; Frattaroli S; Ghiselli A; Balsano F
    Thromb Haemost; 1982 Oct; 48(2):166-8. PubMed ID: 6217577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiaggregant effect of ticlopidine in atherosclerotic patients.
    Manotti C; Potì R; Megna A; Poli T; Alberani M
    Farmaco Prat; 1982 Oct; 37(10):325-30. PubMed ID: 7140941
    [No Abstract]   [Full Text] [Related]  

  • 6. [Platelet aggregation and antiaggregant drugs].
    Andriani A; Chiappetta MG; Fabiani M
    Recenti Prog Med; 1982 Nov; 73(5):537-42. PubMed ID: 6761807
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.
    Verstraete M
    Agents Actions Suppl; 1984; 15():173-87. PubMed ID: 6091423
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic and metabolic characteristics of ticlopidine in relation to its inhibitory properties on platelet function.
    Picard-Fraire C
    Agents Actions Suppl; 1984; 15():68-75. PubMed ID: 6385655
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of platelet aggregation inhibition].
    Abiko Y; Ashida S
    Rinsho Byori; 1979; Suppl 40():169-80. PubMed ID: 233105
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview: pharmacology of ticlopidine.
    Gordon JL
    Agents Actions Suppl; 1984; 15():108-15. PubMed ID: 6385643
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanisms of action of ticlopidine.
    Bruno JJ
    Thromb Res Suppl; 1983; 4():59-67. PubMed ID: 6356466
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.